U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07559903) titled 'ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)' on April 24.

Brief Summary: The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.

Study Start Date: May, 2026

Study Type: OBSERVATIONAL

Condition: Coronary Artery Disease

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Emory University

Information provided by (Resp...